Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study
Public Health · 2023
DOI: 10.1016/j.puhe.2023.10.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health, 2023. Verfasst von A Šavrova und 3 weiteren Autor:innen. Beteiligte Einrichtung: North Estonia Medical Centre Foundation, Womens Clinic, J. Sütiste tee 19, 13419, Tallinn, Estonia. Electronic address: aleksandra.savrova@regionaalh…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Papillomavirus Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eesti Teadusagentuur.
Abstract (Originalsprache)
OBJECTIVES: Cervical cancer (CC) remains a crucial public health issue in Estonia, with high incidence and late diagnosis. The aim of this study was to examine time trends of stage-specific CC incidence in Estonia and factors associated with advanced-stage diagnosis of CC. STUDY DESIGN: This was a nationwide population-based retrospective study. METHODS: Data on CC cases diagnosed in Estonia in 2007-2018 were obtained from the Estonian Cancer Registry, including tumour, nodes, metastases stage at diagnosis. Sociodemographic data were obtained from the Population Registry. To estimate the risk of advanced-stage diagnosis (stages II-IV vs stage I) associated with sociodemographic factors, Poisson regression with robust variance was used to calculate univariate and multivariate prevalence ratios (PR) with 95% confidence intervals (CIs). Time trends of stage-specific CC incidence for 2005-2019 were examined with joinpoint analysis. RESULTS: Incidence of stage I CC showed a significant decline of 4.9% per year since 2007, whereas no change was seen for other stages. Of the 2046 women diagnosed in 2007-2018, 1137 (55.6%) were diagnosed at an advanced stage; this proportion increased from 51% in 2007-2009 to 58% in 2015-2018 (P = 0.004). Multivariate regression analysis showed that advanced-stage diagnosis was associated with age (PR 2.16, 95% CI 1.87-2.49 for women aged ≥75 years compared with those aged 30-44 years), educational level (PR 1.32, 95% CI 1.15-1.51 for women with basic/primary education compared to university education) and marital status (PR 1.14, 95% CI 1.01-1.29 for single women compared to married/cohabiting women). No associations were observed by region of residence or nationality. CONCLUSIONS: To reduce CC mortality, it is crucial to improve prevention and early diagnosis of CC in Estonia through human papillomavirus vaccination and effective and quality-assured screening particularly targeting high-risk groups as well as encouraging symptom awareness and regular check-ups among older women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- North Estonia Medical Centre Foundation, Womens Clinic, J. Sütiste tee 19, 13419, Tallinn, Estonia. Electronic address: aleksandra.savrova@regionaalhaigla.ee.
- Institute of Clinical Medicine, University of Tartu, L, Puusepa 8, 50406, Tartu, Estonia.
- National Institute for Health Development, Department of Epidemiology and Biostatistics, Hiiu 42, 11619, Tallinn, Estonia.
Förderung
- Eesti Teadusagentuur
Zitieren
APA
Šavrova, A., Jaal, J., Nõmm, O., & Innos, K. (2023). Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study. Public Health. https://doi.org/10.1016/j.puhe.2023.10.025
Vancouver
Šavrova A, Jaal J, Nõmm O, Innos K. Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study. Public Health. 2023. doi:10.1016/j.puhe.2023.10.025
BibTeX
@article{avrova2023,
author = {Šavrova, A and Jaal, J and Nõmm, O and Innos, K},
title = {Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study},
journal = {Public Health},
year = {2023},
doi = {10.1016/j.puhe.2023.10.025}
}
EUVIMED